Juntermanns Benjamin, Manka Paul, Hoyer Dieter Paul, Kaiser Gernot Maximillian, Radunz Sonia, Pracht Wolfgang, Mathé Zoltan, Rath Peter-Michael, Steinmann Jörg, Treckmann Jürgen Walter, Schulze Maren
Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany.
Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany.
Ann Transplant. 2015 May 28;20:297-302. doi: 10.12659/AOT.893122.
Infections are a major cause for morbidity and mortality in liver transplant recipients. So far there has been no study systematically investigating the correlation between the MELD (Model for End-Stage Liver Disease) scoring system and complications caused by infections. The aim of the present retrospective study was to evaluate the impact of the pretransplant MELD score on incidence and mortality of pneumonia and septicemia in liver transplant recipients.
The clinical courses of 201 liver transplant recipients between 12/2006 and 3/2009 were recorded and analyzed on the basis of chart review. Patients were stratified into three groups (pretransplant MELD score: group I 6-20, group II ≥ 21-30, group III ≥ 31-40) and compared in terms of incidence of infection and survival.
The mean pretransplant MELD score was 22 ± 12. There were 81 patients in group I, 65 patients in group II, and 55 patients in group III. There was no difference in incidence of infections between the MELD groups. However, septicemia-associated mortality was significantly higher in group III.
A high MELD score is not associated with higher incidence of infections but it is associated with a significantly higher mortality in the case of septicemia. Prevention of infections is of utmost importance, especially in liver transplant recipients with high MELD scores.
感染是肝移植受者发病和死亡的主要原因。迄今为止,尚无研究系统调查终末期肝病模型(MELD)评分系统与感染所致并发症之间的相关性。本回顾性研究的目的是评估移植前MELD评分对肝移植受者肺炎和败血症发病率及死亡率的影响。
通过查阅病历记录并分析了2006年12月至2009年3月期间201例肝移植受者的临床病程。将患者分为三组(移植前MELD评分:I组6 - 20分,II组≥21 - 30分,III组≥31 - 40分),并比较感染发生率和生存率。
移植前MELD评分的平均值为22±12。I组有81例患者,II组有65例患者,III组有55例患者。MELD分组之间的感染发生率没有差异。然而,III组败血症相关死亡率显著更高。
高MELD评分与更高的感染发生率无关,但在败血症情况下与显著更高的死亡率相关。预防感染至关重要,尤其是对于MELD评分高的肝移植受者。